Crossmark

Analysis of medications change in Parkinson’s disease progression data

Crossref DOI link: https://doi.org/10.1007/s10844-018-0502-y

Published Online: 2018-03-20

Published Print: 2018-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Valmarska, Anita

Miljkovic, Dragana

Lavrač, Nada

Robnik-Šikonja, Marko
Funding

Funding for this research was provided by:

PD˙manager project, EU Framework Program for Research and Innovation Horizon 2020 (643706)

HBP SGA1, EU Framework Program for Research and Innovation Horizon 2020 (720270)

Javna Agencija za Raziskovalno Dejavnost RS (P2-0103 - Junior Researcher Program, 37486)

Javna Agencija za Raziskovalno Dejavnost RS (P2-0103)

Javna Agencija za Raziskovalno Dejavnost RS (P2-0209)

PD˙manager project, EU Framework Program for Research and Innovation Horizon 2020 (643706)

HBP SGA1, EU Framework Program for Research and Innovation Horizon 2020 (720270)
License Information

Text and Data Mining valid from 2018-03-20
More Information

Article History

Received: 17 July 2017

Revised: 9 February 2018

Accepted: 19 February 2018

First Online: 20 March 2018

Change Date: 22 June 2018

Change Type: Correction

Change Details: The original version of this article unfortunately contained a mistake. Figure 4 and Figure 5 in Section 5.4 have mistakenly been switched, while the captions of Figure 4 and Figure 5 are correct and correspond to the references in the text. The corrected figures are shown next page.